NasdaqGM - Delayed Quote USD
Tango Therapeutics, Inc. (TNGX)
2.2900
+0.7900
+(52.67%)
At close: May 19 at 4:00:00 PM EDT
2.4100
+0.12
+(5.24%)
After hours: May 19 at 7:59:24 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -0.35 | -0.35 | -1.34 | -1.32 |
| Low Estimate | -0.4 | -0.46 | -1.54 | -1.58 |
| High Estimate | -0.27 | -0.28 | -1.14 | -1.09 |
| Year Ago EPS | -0.24 | -0.27 | -1.19 | -1.34 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 6.41M | 6.48M | 28.67M | 28.86M |
| Low Estimate | 4.54M | 4.77M | 21.57M | 21.57M |
| High Estimate | 8.5M | 8.5M | 42.07M | 42.07M |
| Year Ago Sales | 19.88M | 11.61M | 42.07M | 28.67M |
| Sales Growth (year/est) | -67.77% | -44.20% | -31.84% | 0.64% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.37 | -0.34 | -0.35 |
| EPS Actual | -0.24 | -0.27 | -0.34 | -0.36 |
| Difference | 0.11 | 0.1 | 0 | -0.01 |
| Surprise % | 31.67% | 27.94% | 0.81% | -4.09% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.35 | -0.35 | -1.34 | -1.32 |
| 7 Days Ago | -0.35 | -0.35 | -1.37 | -1.4 |
| 30 Days Ago | -0.35 | -0.35 | -1.37 | -1.38 |
| 60 Days Ago | -0.35 | -0.34 | -1.3 | -1.36 |
| 90 Days Ago | -0.38 | -0.37 | -1.44 | -1.5 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 2 |
| Up Last 30 Days | 1 | 1 | 1 | 2 |
| Down Last 7 Days | 3 | 3 | 3 | 2 |
| Down Last 30 Days | 4 | 4 | 4 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TNGX | -43.87% | -30.00% | -12.68% | 1.40% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/14/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 12/5/2024 |
| Maintains | B. Riley Securities: Buy to Buy | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
| Maintains | Guggenheim: Buy to Buy | 11/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/28/2024 |
Related Tickers
RLAY Relay Therapeutics, Inc.
2.9300
+4.27%
RVMD Revolution Medicines, Inc.
39.93
+0.99%
IDYA IDEAYA Biosciences, Inc.
18.08
+1.46%
ERAS Erasca, Inc.
1.2300
-4.28%
ARVN Arvinas, Inc.
6.53
+0.62%
KYMR Kymera Therapeutics, Inc.
30.20
-0.17%
NRIX Nurix Therapeutics, Inc.
9.51
-0.52%
BCYC Bicycle Therapeutics plc
8.63
+6.54%
ACRV Acrivon Therapeutics, Inc.
1.1800
+2.61%
ORIC ORIC Pharmaceuticals, Inc.
5.14
+8.67%